Previous 10 | Next 10 |
Aptorum Group Limited (Nasdaq: APM) (“the Company”) a pharmaceutical company dedicated to developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs, announced today the Company’s addition to the Morgan Stanley C...
Aeneas Capital and Pyrinas, both affiliated companies to Aptorum Group Ltd (Nasdaq: APM), is launching its flagship fund - Pyrinas US Healthcare Real Estate Fund 1 SP – to acquire and develop co-working space and incubator facilities for the life sciences sector in the United States...
Claves Life Sciences Limited, a wholly owned subsidiary of Aptorum Group Limited ("Aptorum") (Nasdaq: APM), is excited to announce the establishment of a novel therapeutic platform for the treatment of various diseases via modulation of the chemical signaling relating to gut microbiota. The ...
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Argus Research, an independent investment research firm, has launched Equity Research Report coverage on Aptorum Group Limited (NasdaqGM: APM) Click here to view Full Argus Report Highlights, as conveyed by Argus Analyst Stev...
Aptorum Group Limited (Nasdaq: APM), Aeneas Capital Limited, and A*ccelerate Technologies Pte Ltd, the enterprise office of the Agency for Science, Technology and Research (A*STAR), have signed a USD$90 million agreement to co-create local deep tech start-ups in the healthcare and life scien...
Aptorum Group Limited (Nasdaq:APM) is excited to announce the launch and issuance of its asset backed Smart Pharma Token (“ SMPT ”) by its wholly owned subsidiary group, Smart Pharma group and Smart Pharmaceutical Limited Partnership (“ SPLP ”) targeted in May 201...
Aptorum Group Limited (Nasdaq: APM) today announced the establishment of a new subsidiary group, Smart Pharma (“SmartP”), which operates its novel computational repurposed drug discovery, modeling and validation platform, together referred to as the “Smart-ACT TM ”...
Aptorum Group Limited (NASDAQ: APM) (“Aptorum” or the “Company”), a pharmaceutical company focused on the development and commercialization of therapeutic and diagnostic technologies to tackle unmet medical needs, announced today that the Company, in a privately-n...
Aptorum Group Limited (NASDAQ: APM ): FY GAAP EPS of -$0.53. More news on: Aptorum Group Limited, Earnings news and commentary, Read more ...
Aptorum Group Ltd. (NASDAQ: APM), a preclinical stage pharmaceutical company developing and commercializing a broad portfolio of projects under development of therapeutic and diagnostic technologies to tackle unmet medical needs, today provided a business update and announced financial resul...
News, Short Squeeze, Breakout and More Instantly...
Toronto, Ontario--(Newsfile Corp. - July 17, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) will report its second quarter 2024 financial and operating results after market close on Tuesday, August 13, 2024. Management will host a conference call...
Toronto, Ontario--(Newsfile Corp. - July 16, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) announced that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market making services, including use of its proprieta...
Toronto, Ontario--(Newsfile Corp. - July 11, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) ( "Andean" or the "Company" ) is pleased to announce the appointment of Sylvain Lessard as President and General Manager of Golden Queen Mine, effective today, July 11, 2024. Wi...